Skip to main content

Federal Judge Drops Argon Medical From An IVC Filter Case

Federal Judge Drops Argon Medical From An IVC Filter Case

Federal Judge Drops Argon Medical From An IVC Filter Case

Introduction

On Monday, an order was filed in which U.S. District Judge Gershwin A. Drain released Argon Medical Devices Inc. from an inferior vena cava (IVC) filter lawsuit filed by a woman who allegedly suffered from injuries following implantation.

According to the April 12 order, the Michigan federal judge ruled that plaintiff failed to plausibly allege that the seller failed to exercise reasonable care and breached an express warranty as to the device. Two of the four claims made against Rex Medical Inc., another defendant in the lawsuit, were also dismissed and the company will now only face negligence and breach of implied warranty claims.

In 2014, the plaintiff underwent surgery for the Option filter, which is manufactured by Rex and marketed by Argon. In 2017, the woman underwent another surgery to retrieve the filter. The filter was found broken and a fractured strut on the implant had moved and injured her.

The woman filed a lawsuit against both the companies alleging negligence, breach of implied and express warranty, and negligent misrepresentation.

In the recent opinion, Judge Drain noted that Argon is a non-manufacturer seller and so carries different standards for claims as compared to the manufacturer, which requires the plaintiff to allege that the company breached a duty to care. The judge further added that plaintiff's complaint is devoid of facts as to when, how, and by whom the express warranty was made, which she alleged as breached.

The plaintiff's claims against Rex survived as the judge found enough specific facts for the claims to withstand complete dismissal. However, the negligent misrepresentation claims against Rex were dropped as the judge believed that the plaintiff failed to specify what misrepresentations the company made to her in its advertising.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!